G

Serial Number 98241703
730

Registration Progress

Application Filed
Oct 26, 2023
Under Examination
Feb 25, 2025
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Feb 25, 2026 119 days

Trademark Image

G

Basic Information

Serial Number
98241703
Filing Date
October 26, 2023
Published for Opposition
December 31, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
730
Status Date
Aug 18, 2025
Application
Pending
Classes
001 005 040 042

Rights Holder

GreenLight Biosciences, Inc.

03
Address
9 Laboratory Drive, Suite 300
Durham, NC 27709

Ownership History

GreenLight Biosciences, Inc.

Original Applicant
03
Durham, NC

GreenLight Biosciences, Inc.

Owner at Publication
03
Durham, NC

Legal Representation

Attorney
Rachelle A. Dubow, Esq.

USPTO Deadlines

Next Deadline
119 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
February 25, 2026
Extension Available
Until February 25, 2026

Application History

23 events
Date Code Type Description Documents
Aug 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 18, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 18, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 18, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 5, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 5, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 26, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 26, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 26, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical preparations for the treatment of seeds, plants and crops to improve plant health and yield
Class 005
Chemical reagents and RNA sequences, namely, insecticides, pesticides, and fungicides, used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, herbicides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutic pharmaceuticals for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutic nucleic acids and siRNA therapeutic nucleic acids for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancer
Class 040
Cell-Free processing and manufacturing of RNA for others; biological manufacturing and cell-free processing of RNA for others
Class 042
Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; custom design of pesticides, insecticides, and fungicides, computer-aided design services and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use

Additional Information

Design Mark
The mark consists of a stylized letter G.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
GREEN LIGHT

Classification

International Classes
001 005 040 042